Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.

Autor: Welsh-Bohmer KA; Department of Psychiatry & Neurology Duke University Durham North Carolina USA., Kerchner GA; Pharma Research and Early Development F. Hoffmann-La Roche, Ltd Basel Switzerland., Dhadda S; Eisai Inc. Nutley New Jersey USA., Garcia M; Boehringer Ingelheim Pharmaceuticals Inc. Ridgefield Connecticut USA., Miller DS; Signant Health Blue Bell Pennsylvania USA., Natanegara F; Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana USA., Raket LL; Novo Nordisk A/S Søborg Denmark., Robieson W; AbbVie North Chicago Illinois USA., Siemers ER; ACUMEN Pharmaceuticals Charlottesville Virginia USA., Carrillo MC; Alzheimer's Association Chicago Illinois USA., Weber CJ; Alzheimer's Association Chicago Illinois USA.

Publikováno v: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2023 Oct 18; Vol. 9 (4), pp. e12421. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).

Levodopa-carbidopa intestinal gel in the treatment of patients with parkinson disease: Results of a 12-month open study

Autor: Skoromets A., Odinak M., Yakupov E., Litvinenko I., Zalyalova Z., Timofeeva A., Kirtaev S., Bogdanov R., Agafina A., Chatamra K., Robieson W., Benesh J., Latypova G., Ershova M., Illarioshkin S.

Publikováno v: SCOPUS19977298-2017-117-2-SID85016086609

© 2017, Media Sphera. All rights reserved.Objective: To evaluate the long-term safety and efficacy of intrajejunal levodopa-carbidopa intestinal gel (LCIG) infusion in the treatment of patients with severe stages of Parkinson disease (PD) who did no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1eaf342df0026a9770cbc0d79cd4d275
https://openrepository.ru/article?id=223001

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.

Autor: Aldred J; Selkirk Neurology & Inland Northwest Research, Spokane, 610 S Sherman St #201 & 208, Spokane, WA 99202, USA., Anca-Herschkovitsch M; Department of Neurology, Edith Wolfson Medical Center Affiliated to Tel Aviv University, 62 Ha-Lokhamim St, Holon, Israel., Antonini A; Department of Neuroscience, Padua University, 5 - 35128 Padova, Padua, Veneto, Italy., Bajenaru O; Department of Neurology, University of Medicine & Pharmacy 'Carol Davila', Bulevardul Eroii Sanitari 8, Bucharest, Romania., Bergmann L; AbbVie, Inc., 1 Waukegan Rd, North Chicago, IL 60064, USA., Bourgeois P; Department of Neurology AZ Groeninge, President Kennedylaan 4, Kortrijk, Belgium., Cubo E; Neurology Department, Hospital Universitario Burgos, Av. Islas Baleares, 3, Burgos, Spain., Davis TL; Department of Neurology, Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, TN 37232, USA., Iansek R; Kingston Centre, Monash Health, 400 Warrigal Rd, Melbourne, Victoria, Australia., Kovács N; Department of Neurology, University of Pecs, 48-as tér 1, Pecs, Hungary., Kukreja P; AbbVie, Inc., 1 Waukegan Rd, North Chicago, IL 60064, USA., Onuk K; AbbVie, Inc., 1 Waukegan Rd, North Chicago, IL 60064, USA., Pontieri FE; Department of Neurological Sciences, Sapienza University of Rome, Piazzale Aldo Moro, 5, Rome, Italy., Robieson W; AbbVie, Inc., 1 Waukegan Rd, North Chicago, IL 60064, USA., Siddiqui MS; Department of Neurology, Wake Forest School of Medicine, 475 Vine St, Winston Salem, NC 27101, USA., Simu M; Department of Neurology, Victor Babes University of Medicine & Pharmacy, Piaţa Eftimie Murgu 2, Timisoara, Romania., Standaert DG; Department of Neurology, University of Alabama at Birmingham, 1720 University Blvd, Birmingham, AL 35294, USA., Chaudhuri KR; Parkinson Foundation International Centre of Excellence, King's College & King's College Hospital, Denmark Hill, London, UK.

Publikováno v: Neurodegenerative disease management [Neurodegener Dis Manag] 2020 Oct; Vol. 10 (5), pp. 309-323. Date of Electronic Publication: 2020 Sep 02.